RCMI Coordinating Center (RCMI CC)
Home
About
RCMI Coordinating Center
Overview
Sharing Data
Network Graph
Help
History (2)
Knowledge Gaps, Challenges, and Opportunities in Health and Prevention Research for Asian Americans, Native Hawaiians, and Pacific Islanders: A Report From the 2021 National Institutes of Health Workshop.
Reverse type I inhibitor of Mycobacterium tuberculosis CYP125A1.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Reverse type I inhibitor of Mycobacterium tuberculosis CYP125A1.
Ouellet H, Kells PM, Ortiz de Montellano PR, Podust LM. Reverse type I inhibitor of Mycobacterium tuberculosis CYP125A1. Bioorg Med Chem Lett. 2011 Jan 01; 21(1):332-7.
View in:
PubMed
subject areas
Antitubercular Agents
Binding Sites
Catalytic Domain
Computer Simulation
Crystallography, X-Ray
Cytochrome P-450 Enzyme System
Enzyme Inhibitors
Mycobacterium tuberculosis
Protein Binding
Spectrophotometry, Ultraviolet
authors with profiles
Hugues Ouellet